CURI vs LION

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CURI

36.9
AI Score
VS
CURI Wins

LION

49.1
AI Score

Investment Advisor Scores

CURI

37score
Recommendation
SELL

LION

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI LION Winner
Forward P/E 14.7059 28.5714 CURI
PEG Ratio 0 0 Tie
Revenue Growth 22.3% 0.0% CURI
Earnings Growth 1400.0% 0.0% CURI
Tradestie Score 36.9/100 49.1/100 LION
Profit Margin 0.0% 0.0% CURI
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD LION

Relative Price Performance (Last 90 Days)

CURI 1M: +16.0% · 3M: +7.0% LION 1M: -14.1% · 3M: -10.8%

Current Technical Phase

CURI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.7%) with fading momentum, RSI 49

RSI (14): 48.6 · Price: $2.76

LION

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.9%), weak momentum, RSI 29

RSI (14): 28.7 · Price: $11.51

Fundamentals Snapshot

Metric CURI LION
Market Cap
Forward P/E 8.9 51.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.6%
Operating Margin 0.4% 0.0%
EPS -0.01 -0.17
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, CURI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.